Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
The board of directors of Targovax ASA (the "Company"), has on 9 February 2017, in accordance with the authorisations granted by the general meeting 13 April 2016, resolved: · to increase the share capital of up to NOK 103,037.50 by issuance of up to 1,030,375 new shares, each with a nominal value of NOK 0.10 in order to facilitate the exercise of vested employee options; and · to increase the share capital of up to NOK 6,987.90 by issuance of up to 69,879 new shares, each with a nominal value of NOK 0.10 in order to facilitate the settlement of vested restricted stock units ("RSUs")